Stem Cell King Pharma Private Limited - Company Profile

It is a healthcare private limited company based in Ludhiana, Punjab, India, established in 2007.
2007 Ludhiana, Punjab, India Struck Off
Last Updated:
Access Report
About Stem Cell King Pharma Private Limited

Stem Cell King Pharma Private Limited, a struck off private limited company, was established on 01 August 2007 in Ludhiana, Punjab, India. Engaging in human health activities within the healthcare sector, it holds CIN: U85110PB2007PTC031291. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹1.00 M.

Its leadership includes Karan Goel (Director), Gaurav Goel (Director). Past directors included Alfred T Sapse. It is based at D-127 Focal Point Phase-V, Ludhiana, Punjab, 141010.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85110PB2007PTC031291

  • Registration Number

    031291

  • Incorporation Date

    01 August 2007

  • Authorized Capital

    ₹1.00 M

  • ROC Code

    Roc Chandigarh

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Company Age 18 Year, 6 Months
Company report

Stem Cell King Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Stem Cell King Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Stem Cell King Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Karan Goel Director 01 Aug 2007 Current
Gaurav Goel Director 01 Aug 2007 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 30 May 2010 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Stem Cell King Pharma.

Enhance accessibility to Stem Cell King Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Stem Cell King Pharma revenue growth over time
Stem Cell King Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Stem Cell King Pharma?

Unlock access to Stem Cell King Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Stem Cell King Pharma?

Unlock and access historical data on people associated with Stem Cell King Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Stem Cell King Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stem Cell King Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Stem Cell King Pharma
Recent Activity within the Organization
  • Director Appointment

    Karan Goel was appointed as a Director was appointed as a Director on 01 Aug 2007 & has been associated with this company since 18 years 6 months . was recorded as a recent event.

  • Director Appointment

    Gaurav Goel was appointed as a Director was appointed as a Director on 01 Aug 2007 & has been associated with this company since 18 years 6 months . was recorded as a recent event.

  • Company Incorporation

    The activity Stem Cell King Pharma Private Limited was registered on 01 Aug 2007 with Roc Chandigarh & aged 18 years 6 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Stem Cell King Pharma Private Limited?

The CIN of Stem Cell King Pharma Private Limited is U85110PB2007PTC031291.

Where is Stem Cell King Pharma Private Limited headquartered?

Stem Cell King Pharma Private Limited is headquartered at D-127 Focal Point Phase-V, Ludhiana, Punjab, 141010.

When was Stem Cell King Pharma Private Limited incorporated?

Stem Cell King Pharma Private Limited was incorporated on 01 August 2007.

Who are the current directors of Stem Cell King Pharma Private Limited?

The current directors of Stem Cell King Pharma Private Limited are

What is the primary industry of Stem Cell King Pharma Private Limited?

The primary industry of Stem Cell King Pharma Private Limited is Healthcare.

Is Stem Cell King Pharma Private Limited a listed company?

Stem Cell King Pharma Private Limited is unlisted.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available